Study details
Enrolling now
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
Memorial Sloan Kettering Cancer Center
NCT IDNCT06637462ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 3 years
Ages
18+
Locations
6 sites in NJ, NY
About this study
Researchers are testing how people with rectal cancer respond to standard treatment (chemoradiation and chemotherapy) before surgery. The trial will use blood, tissue, and scan results to see if the response to this treatment can predict whether a person's cancer gets better, worse, or stays the same after treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Endoscopy
Primary goalClinical response
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Clinical response
Procedures
diagnostic
Body systems
Oncology